154 related articles for article (PubMed ID: 29685843)
21. Enhanced Expression of Anti-CD19 Chimeric Antigen Receptor in
Morita D; Nishio N; Saito S; Tanaka M; Kawashima N; Okuno Y; Suzuki S; Matsuda K; Maeda Y; Wilson MH; Dotti G; Rooney CM; Takahashi Y; Nakazawa Y
Mol Ther Methods Clin Dev; 2018 Mar; 8():131-140. PubMed ID: 29687032
[TBL] [Abstract][Full Text] [Related]
22. CAR T-cells: A John von Neumann legacy?
Quesnel B
Curr Res Transl Med; 2018 May; 66(2):35-36. PubMed ID: 29685844
[No Abstract] [Full Text] [Related]
23. [The care process of patient receiving CAR T-cell therapy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Beauvais D; Andrianne C; Aubrun C; Berquier M; Bole S; Caulier A; Courbon C; Delorme J; Fournier I; François G; Jaivenois MF; Le Bars L; Mussot I; Vercasson M; Wallart Brejaud A; Yakoub-Agha I; Lacroix D
Bull Cancer; 2020 Dec; 107(12S):S170-S177. PubMed ID: 32891406
[TBL] [Abstract][Full Text] [Related]
24. [Reporting data of patients receiving CAR T cell therapy into the EBMT registry: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Vasseur A; Karam M; Chaillou D; Colonnese E; Dantin C; Latiere C; Meziane Y; Pereira M; Yakoub-Agha I; Chabannon C; Raus N
Bull Cancer; 2020 Dec; 107(12S):S178-S184. PubMed ID: 31831153
[TBL] [Abstract][Full Text] [Related]
25. Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy.
Yakoub-Agha I; Greco R; Onida F; de la Cámara R; Ciceri F; Corbacioglu S; Dolstra H; Glass B; Kenyon M; McLornan DP; Neven B; de Latour RP; Peric Z; Ruggeri A; Snowden JA; Sureda A; Sánchez-Ortega I
Bone Marrow Transplant; 2023 Jun; 58(6):696-700. PubMed ID: 36973515
[TBL] [Abstract][Full Text] [Related]
26. Practical issues in CAR T-cell therapy.
Byun JM
Blood Res; 2023 Apr; 58(S1):S11-S12. PubMed ID: 36843380
[TBL] [Abstract][Full Text] [Related]
27. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. I: Structuring centers for the multidisciplinary clinical administration and management of CAR-T cell therapy patients.
Clé DV; Hirayama AV; Alencar AJ; Costa LJ; Feliciano JVP; Mattos ER; Cordeiro AC; Salvino MA; Barros GMN; de Lima M; Scheinberg P; Guerino-Cunha RL
Hematol Transfus Cell Ther; 2021 Nov; 43 Suppl 2(Suppl 2):S3-S12. PubMed ID: 34794793
[TBL] [Abstract][Full Text] [Related]
28. Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE).
Yakoub-Agha I; Chabannon C; Bader P; Basak GW; Bonig H; Ciceri F; Corbacioglu S; Duarte RF; Einsele H; Hudecek M; Kersten MJ; Köhl U; Kuball J; Mielke S; Mohty M; Murray J; Nagler A; Robinson S; Saccardi R; Sanchez-Guijo F; Snowden JA; Srour M; Styczynski J; Urbano-Ispizua A; Hayden PJ; Kröger N
Haematologica; 2020; 105(2):297-316. PubMed ID: 31753925
[TBL] [Abstract][Full Text] [Related]
29. CAR-T Cell Therapy in Diffuse Large B Cell Lymphoma: Hype and Hope.
Hopfinger G; Jäger U; Worel N
Hemasphere; 2019 Apr; 3(2):e185. PubMed ID: 31723824
[TBL] [Abstract][Full Text] [Related]
30. [Indications and follow-up for autologous hematopoietic stem cell transplantation in multiple sclerosis: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) in association with the Francophone Society of Multiple Sclerosis].
Zephir H; Puyade M; Gueguen A; Michel L; Terriou L; Dive D; Laureys G; Mathey G; Labauge P; Marjanovic Z; Pugnet G; Badoglio M; Lansiaux P; Yakoub-Agha I; Béguin Y; Farge D
Bull Cancer; 2019 Jan; 106(1S):S92-S101. PubMed ID: 30527815
[TBL] [Abstract][Full Text] [Related]
31. [Quality assessment of CAR T-cell activity: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Duléry R; Lacassagne MN; Giraud C; Ader V; Beaumont JL; Carnoy S; Carpentier A; Fegueux N; Gibault-Joffe C; Guerout-Verite MA; Huynh TNP; Lewalle P; Perrin A; Plaza-Milhe S; Bonnin A; Yakoub-Agha I; Contentin N
Bull Cancer; 2020 Dec; 107(12S):S193-S201. PubMed ID: 33187683
[TBL] [Abstract][Full Text] [Related]
32. [Stem cell transplantation unit: Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)].
Faucher C; Adam C; Bancillon N; Bertrand E; Colledani F; de Berranger E; Denis V; Girard I; Hamzy F; Loukili N; Mannone L; Mercier L; Perrin A; Vasseur A; Asma Q; Bompoint C; Yafour N; Yakoub-Agha I; Jost E
Bull Cancer; 2019 Jan; 106(1S):S1-S9. PubMed ID: 30580913
[TBL] [Abstract][Full Text] [Related]
33. Clinical units to set up chimeric antigen receptor T-cell therapy (CAR T-cells): Based on the recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
Yakoub-Agha I
Curr Res Transl Med; 2018 May; 66(2):57-58. PubMed ID: 29685843
[TBL] [Abstract][Full Text] [Related]
34. [How to deal with an unexpected event that could alter the normal activity of cellular therapy? Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Bay JO; Beguin Y; Carpentier A; Dard C; Guillaume T; Labussiere-Wallet H; Lacassagne MN; Sauze S; Yakoub-Agha I; Chalandon Y
Bull Cancer; 2021 Dec; 108(12S):S20-S25. PubMed ID: 34215432
[TBL] [Abstract][Full Text] [Related]
35. [Medium-term follow-up of patients treated with chimeric antigen receptor T cells (CAR T cells): Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Alsuliman T; Drieu La Rochelle L; Campidelli A; Duléry R; Fayard A; Mamez AC; Mear JB; Schneider PO; Trevet A; Vicente C; Yakoub-Agha I
Bull Cancer; 2021 Dec; 108(12S):S65-S71. PubMed ID: 33678408
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
